Mills KT, Stefanescu A, He J. The global epidemiology of hypertension. Nat Rev Nephrol. 2020;16(4):223–37.
Article
CAS
PubMed
PubMed Central
Google Scholar
Fisher ND, Curfman G. Hypertension—a public health challenge of global proportions. JAMA. 2018;320(17):1757–9.
Article
PubMed
Google Scholar
Zeng Z, Chen J, Xiao C, Chen W. A global view on prevalence of hypertension and human develop index. Ann Global Health. 2020;86(1):67.
Article
Google Scholar
Egan BM, Kjeldsen SE, Grassi G, Esler M, Mancia G. The global burden of hypertension exceeds 1.4 billion people: should a systolic blood pressure target below 130 become the universal standard? J Hypertens. 2019;37(6):1148–53.
Article
CAS
PubMed
Google Scholar
Mirzaei M, Moayedallaie S, Jabbari L, Mohammadi M. Prevalence of hypertension in Iran 1980–2012: a systematic review. J Tehran Heart Cent. 2016;11(4):159–67.
PubMed
PubMed Central
Google Scholar
Eze II, Mbachu CO, Azuogu BN, Ossai E, Unah AI, Akamike IC, et al. Effect of on-site behavioural modification intervention on lifestyle risk factors of hypertension among adult market traders in Abakaliki, Nigeria. Int J Health Promot Edu. 2021;59(1):35–49.
Article
Google Scholar
Ostchega Y, Zhang G, Hughes JP, Nwankwo T. Factors associated with hypertension control in US adults using 2017 ACC/AHA guidelines: National Health and Nutrition Examination Survey 1999–2016. Am J Hypertens. 2018;31(8):886–94.
Article
PubMed
Google Scholar
Avgerinos KI, Spyrou N, Mantzoros CS, Dalamaga M. Obesity and cancer risk: emerging biological mechanisms and perspectives. Metabolism. 2019;92:121–35.
Article
CAS
PubMed
Google Scholar
Koliaki C, Liatis S, Kokkinos A. Obesity and cardiovascular disease: revisiting an old relationship. Metabolism. 2019;92:98–107.
Article
CAS
PubMed
Google Scholar
Trends in obesity and diabetes across Africa from 1980 to 2014: an analysis of pooled population-based studies. Int J Epidemiol. 2017;46(5):1421–32.
Darbandi M, Pasdar Y, Moradi S, Mohamed HJJ, Hamzeh B, Salimi Y. Discriminatory capacity of anthropometric indices for cardiovascular disease in adults: a systematic review and meta-analysis. Prev Chronic Dis. 2020;17:E131.
Article
PubMed
PubMed Central
Google Scholar
Cӑtoi AF, Pârvu AE, Andreicuț AD, Mironiuc A, Crӑciun A, Cӑtoi C, et al. Metabolically healthy versus unhealthy morbidly obese: chronic inflammation, nitro-oxidative stress, and insulin resistance. Nutrients. 2018;10(9):1199.
Article
PubMed Central
Google Scholar
Kim Y, Chang Y, Cho YK, Ahn J, Shin H, Ryu S. Metabolically healthy versus unhealthy obesity and risk of fibrosis progression in non-alcoholic fatty liver disease. Liver Int. 2019;39(10):1884–94.
Article
CAS
PubMed
Google Scholar
Hsu ARC, Ames SL, Xie B, Peterson DV, Garcia L, Going SB, et al. Incidence of diabetes according to metabolically healthy or unhealthy normal weight or overweight/obesity in postmenopausal women: the Women’s Health Initiative. Menopause. 2020;27(6):640–7.
Article
Google Scholar
Blüher M. Metabolically healthy obesity. Endocr Rev. 2020;41(3):405–20.
Article
Google Scholar
Pasdar Y, Najafi F, Moradinazar M, Shakiba E, Karim H, Hamzeh B, et al. Cohort profile: Ravansar non-communicable disease cohort study: the first cohort study in a Kurdish population. Int J Epidemiol. 2019;48:682–3.
Article
PubMed
Google Scholar
Poustchi H, Eghtesad S, Kamangar F, Etemadi A, Keshtkar A-A, Hekmatdoost A, et al. Prospective epidemiological research studies in Iran (the PERSIAN Cohort Study): rationale, objectives, and design. Am J Epidemiol. 2017;187(4):647–55.
Article
PubMed Central
Google Scholar
Pasdar Y, Moradi S, Moludi J, Saiedi S, Moradinazar M, Hamzeh B, et al. Waist-to-height ratio is a better discriminator of cardiovascular disease than other anthropometric indicators in Kurdish adults. Sci Rep. 2020;10(1):1–10.
Article
Google Scholar
Alberti KGM, Zimmet P, Shaw J. The metabolic syndrome—a new worldwide definition. Lancet. 2005;366(9491):1059–62.
Article
PubMed
Google Scholar
Baek T-H, Lee H-Y, Lim N-K, Park H-Y. Gender differences in the association between socioeconomic status and hypertension incidence: the Korean Genome and Epidemiology Study (KoGES). BMC Public Health. 2015;15(1):1–7.
Article
Google Scholar
Luo W, Guo Z, Hao C, Yao X, Zhou Z, Wu M, et al. Interaction of current alcohol consumption and abdominal obesity on hypertension risk. Physiol Behav. 2013;122:182–6.
Article
CAS
PubMed
Google Scholar
Gus M, Fuchs SC, Moreira LB, Moraes RS, Wiehe M, Silva AF, et al. Association between different measurements of obesity and the incidence of hypertension. Am J Hypertens. 2004;17(1):50–3.
Article
PubMed
Google Scholar
Chen Z, Li S, Wang X, Zhang L, Shao L, Tian Y, et al. The incidence of hypertension, overweight, and obesity and relationship with cardiovascular events among middle-aged Chinese: 6 years follow-up results. Zhonghua Xin Xue Guan Bing Za Zhi. 2020;48(1):47–53.
CAS
PubMed
Google Scholar
Leggio M, Lombardi M, Caldarone E, Severi P, D’emidio S, Armeni M, et al. The relationship between obesity and hypertension: an updated comprehensive overview on vicious twins. Hypertens Res. 2017;40(12):947–63.
Article
PubMed
Google Scholar
Ruilope LM, Nunes Filho A, Nadruz W Jr, Rosales FR, Verdejo-Paris J. Obesity and hypertension in Latin America: current perspectives. Hipertension y riesgo vascular. 2018;35(2):70–6.
Article
CAS
PubMed
Google Scholar
Pasdar Y, Moradi S, Hamzeh B, Najafi F, Nachvak SM, Mostafai R, et al. The validity of resting energy expenditure predictive equations in adults with central obesity: a sub-sample of the RaNCD cohort study. Nutr Health. 2019;25(3):217–24.
Article
PubMed
Google Scholar
Hinnouho G-M, Czernichow S, Dugravot A, Batty GD, Kivimaki M, Singh-Manoux A. Metabolically healthy obesity and risk of mortality: does the definition of metabolic health matter? Diabetes Care. 2013;36(8):2294–300.
Article
CAS
PubMed
PubMed Central
Google Scholar
Fingeret M, Marques-Vidal P, Vollenweider P. Incidence of type 2 diabetes, hypertension, and dyslipidemia in metabolically healthy obese and non-obese. Nutr Metab Cardiovasc Dis. 2018;28(10):1036–44.
Article
CAS
PubMed
Google Scholar
Yuan Y, Mu J-J, Chu C, Zheng W-L, Wang Y, Hu J-W, et al. Effect of metabolically healthy obesity on the development of arterial stiffness: a prospective cohort study. Nutr Metab. 2020;17(1):1–10.
Article
Google Scholar
Hashimoto Y, Tanaka M, Okada H, Senmaru T, Hamaguchi M, Asano M, et al. Metabolically healthy obesity and risk of incident CKD. Clin J Am Soc Nephrol. 2015;10(4):578–83.
Article
CAS
PubMed
PubMed Central
Google Scholar
Gilardini L, Zambon A, Soranna D, Croci M, Invitti C. Predictors of the transition from metabolically healthy obesity to unhealthy obesity. Eating Weight Disord Stud Anorex Bulim Obes. 2018;23(6):739–44.
Article
Google Scholar
Zhang N, Chen Y, Guo X, Sun G, Dai D, Sun Y. Metabolic abnormalities, but not metabolically healthy obesity, are associated with left ventricular hypertrophy. Heart Lung Circ. 2017;26(3):251–7.
Article
PubMed
Google Scholar
Mongraw-Chaffin M, Foster MC, Anderson CA, Burke GL, Haq N, Kalyani RR, et al. Metabolically healthy obesity, transition to metabolic syndrome, and cardiovascular risk. J Am Coll Cardiol. 2018;71(17):1857–65.
Article
CAS
PubMed
PubMed Central
Google Scholar
Seravalle G, Grassi G. Obesity and hypertension. Pharmacol Res. 2017;122:1–7.
Article
CAS
PubMed
Google Scholar
Pasdar Y, Moradi S, Abdollahzad H, Hamzeh B, Najafi F, Nachvak SM, et al. Accuracy of waist to hip ratio calculated by bioelectric impedance device in the Ravansar non-communicable disease cohort study. Top Clin Nutr. 2019;34(4):269–76.
Article
Google Scholar
Jiang P, Ma D, Wang X, Wang Y, Bi Y, Yang J, et al. Astragaloside IV prevents obesity-associated hypertension by improving pro-inflammatory reaction and leptin resistance. Mol Cell. 2018;41(3):244.
CAS
Google Scholar
Lambert EA, Straznicky NE, Dixon JB, Lambert GW. Should the sympathetic nervous system be a target to improve cardiometabolic risk in obesity? Am J Physiol Heart Circ Physiol. 2015;309(2):H244–58.
Article
CAS
PubMed
Google Scholar
Aronow WS. Association of obesity with hypertension. Ann Transl Med. 2017;5(17):350.
Article
PubMed
PubMed Central
Google Scholar
Cwynar M, Gąsowski J, Gryglewska B, Głuszewska A, Kwater A, Królczyk J, et al. Insulin resistance and renal sodium handling influence arterial stiffness in hypertensive patients with prevailing sodium intake. Am J Hypertens. 2019;32(9):848–57.
Article
PubMed
Google Scholar
Ohashi K, Kihara S, Ouchi N, Kumada M, Fujita K, Hiuge A, et al. Adiponectin replenishment ameliorates obesity-related hypertension. Hypertension. 2006;47(6):1108–16.
Article
CAS
PubMed
Google Scholar
De Boer MP, Meijer RI, Wijnstok NJ, Jonk AM, Houben AJ, Stehouwer CD, et al. Microvascular dysfunction: a potential mechanism in the pathogenesis of obesity-associated insulin resistance and hypertension. Microcirculation. 2012;19(1):5–18.
Article
PubMed
Google Scholar
Soleimani M. Insulin resistance and hypertension: new insights. Kidney Int. 2015;87(3):497–9.
Article
PubMed
Google Scholar